// App-Quantinova.ai

10574 : Correlation of ERCC1 expression on circulating tumor cells with progression-free survival in metastatic non-small cell lung cancer patients treated with platinum-based chemotherapy.

Researchers

Presenter

  • Jonathan Riess

Principal Investigators

  • Millie Snigdha Das

  • Paul Henry Frankel

  • Heather A. Wakelee

  • Erich Schwartz

  • Robyn Bennis

  • H Ben Hsieh

  • Xiaohe Liu

  • Janey Ly

  • Lisa Ya Zhou

  • Jorge J. Nieva

  • Richard Bruce

Medical Centers

  • City of Hope, Duarte, CA

  • Palo Alto Research Corporation, Palo Alto, CA

  • Stanford University Cancer Institute, Stanford, CA

  • Stanford School of Medicine, Stanford, CA

  • Billings Clinic, Billings, MA

  • Stanford University Cancer Institute, Stanford, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

  • Excision repair cross-complementation group 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A